HUTCHMED (China) Ltd
HCMdata completeness 100%12 fiscal years on fileHUTCHMED (China) Ltd earns about -17% on invested capital, but has diluted owners by 10% over 5 years — worth asking whether the growth reaches owners. The applicable estimate puts fair value near $0.45 a share.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $356.1M1 | $426.4M2 | $838M3 | $630.2M3 | $548.5M3 |
| Net income | −$194.6M4 | −$360.8M5 | $100.8M6 | $37.7M6 | $456.9M6 |
| Operating cash flow | −$204.2M7 | −$268.6M8 | $219.3M9 | $497,0009 | −$64.7M9 |
| Capital expenditure | $16.4M10 | $36.7M11 | $32.6M12 | $17.9M12 | $14.1M12 |
| Free cash flow (derived) | −$220.6M7 | −$305.3M8 | $186.6M9 | −$17.4M9 | −$78.8M9 |
| Total debt | $26.9M13 | $36.2M14 | $189.8M15 | $189M16 | $211.3M16 |
| Cash & equivalents | $377.5M17 | $313.3M18 | $283.6M19 | $154M20 | $71.3M20 |
| Diluted shares | 792.7M | 847.1M | 869.2M | 872.8M | 872.9M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $14.18 of net worth that earned you $5.23 and generated −$0.9 of cash last year, against $2.42 of debt.
It earned an average -17% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 10% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has risen 685% over the same window.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
assumptions (8)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- normalizedEarnings$37.7M
- growthAssumed0.0%
assumptions (1)
- grahamMultiplier2250.0%
Different models answer different questions — which to trust when →
- 20-F · period ending 2021-12-31 · accession 0001104659-24-028454 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 20-F · period ending 2022-12-31 · accession 0001410578-25-000377 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 20-F · period ending 2023-12-31 · accession 0001104659-26-023822 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 20-F · period ending 2021-12-31 · accession 0001104659-24-028454 (NetIncomeLoss)
- 20-F · period ending 2022-12-31 · accession 0001410578-25-000377 (NetIncomeLoss)
- 20-F · period ending 2023-12-31 · accession 0001104659-26-023822 (NetIncomeLoss)
- 20-F · period ending 2021-12-31 · accession 0001104659-24-028454 (NetCashProvidedByUsedInOperatingActivities)
- 20-F · period ending 2022-12-31 · accession 0001410578-25-000377 (NetCashProvidedByUsedInOperatingActivities)
- 20-F · period ending 2023-12-31 · accession 0001104659-26-023822 (NetCashProvidedByUsedInOperatingActivities)
- 20-F · period ending 2021-12-31 · accession 0001104659-24-028454 (PaymentsToAcquirePropertyPlantAndEquipment)
- 20-F · period ending 2022-12-31 · accession 0001410578-25-000377 (PaymentsToAcquirePropertyPlantAndEquipment)
- 20-F · period ending 2023-12-31 · accession 0001104659-26-023822 (PaymentsToAcquirePropertyPlantAndEquipment)
- 20-F · period ending 2021-12-31 · accession 0001104659-23-026282 (LongTermDebtCurrent)
- 20-F · period ending 2022-12-31 · accession 0001104659-24-028454 (LongTermDebtNoncurrent)
- 20-F · period ending 2023-12-31 · accession 0001410578-25-000377 (LongTermDebtNoncurrent)
- 20-F · period ending 2024-12-31 · accession 0001104659-26-023822 (LongTermDebtNoncurrent)
- 20-F · period ending 2021-12-31 · accession 0001104659-23-026282 (CashAndCashEquivalentsAtCarryingValue)
- 20-F · period ending 2022-12-31 · accession 0001104659-24-028454 (CashAndCashEquivalentsAtCarryingValue)
- 20-F · period ending 2023-12-31 · accession 0001410578-25-000377 (CashAndCashEquivalentsAtCarryingValue)
- 20-F · period ending 2024-12-31 · accession 0001104659-26-023822 (CashAndCashEquivalentsAtCarryingValue)